Large gastrointestinal tract arteriovenous malformations (AVMs), consisting of direct connections between arteries and veins that lack intervening capillaries, can result in chronic anemia and gastrointestinal hemorrhage, and are seen primarily in patients over age 50 2 .
Additional features of clinical significance include the development of arteriovenous malformations of the lung, liver and brain. AVM-induced pulmonary shunts can cause transient ischemic attacks, strokes, cyanosis and clubbing of the nails as well as predisposing to the development of cerebral abscesses. As a result, antibiotic prophylaxis, using the protocol suggested by the American Heart
Association for the prevention of bacterial endocarditis, is recommended prior to surgical intervention for patients with suspected HHT until the presence of pulmonary AVMs can be ruled out 3 . Because the frequency and size of pulmonary AVMs appear to increase with advancing age, high risk patients without pulmonary AVMs should be rescreened periodically. Pregnant women with pulmonary AVMs are at a high risk for developing lung hemorrhage.
The estimated prevalence of HHT is 2-20 per 100,000 population 1 . There is some evidence of increased prevalence in patients of Anglo-Germanic, Latin, Scandinavian and Jewish ancestry.
Two separate subsets of HHT, HHT1 and HHT2, have been identified 1 .
HHT1 is due to a mutation of the endoglin gene, which codes for a TGF-beta binding protein expressed in endothelial cells and involved in maintaining blood vessel integrity. HHT2 is caused by a mutation of the ALK-1 gene (activin receptor-like kinase-1), a type 1 serine-threonine kinase receptor, also expressed in high levels in endothelial cells. Patients with HHT2 have milder disease of late onset 4 . Patients with an endoglin mutation (HHT1) tend to present with an earlier onset of epistaxis and telangiectases. These patients are also significantly more likely to have pulmonary and cerebral arteriovenous malformations. However, the full spectrum of telangiectases and AVMs can also be seen in patients with an ALK-1 defect (HHT2).
Currently, clinical genetic screening for HHT1 and HHT2 is available in a number of laboratories (for an updated list see www.geneclinics.org). Prenatal testing is also available, but is not widely employed.
A clinical diagnosis can be reached in the presence of 3 of 4 major criteria 5 : recurrent episodes of epistaxis, multiple telangiectases, visceral lesions, and a family history of similarly affected relatives. Patients with only 2 major criteria should be reported as "suspected HHT" and followed closely due to the increased expression of disease traits with advancing age.
Patients with recurrent epistaxis in the absence of telangiectases should be investigated to rule out the possibility of an undiagnosed bleeding diathesis.
Isolated telangiectases are relatively common in otherwise healthy individuals, and can also be seen in the setting of chronic liver disease and pregnancy. The differential diagnosis of a patient with multiple skin and mucosal telangiectases would also include ataxia-telangiectasia, hereditary benign telangiectasia and CREST syndrome 6 (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectases). The appearance and distribution of the telangiectases is quite similar among these conditions.
In addition to oculocutaneous telangiectases, ataxia-telangiectasia is characterized by early onset progressive gait ataxia, progressively slurred speech, oculomotor apraxia, choreoathetosis, frequent infections, and a substantially increased risk of developing hematopoietic malignancies 7 .
Hereditary benign telangiectasia (generalized essential telangiectasia) is a rare benign inherited disorder characterized by widespread cutaneous telangiectases 8 . In contrast to HHT, bleeding is uncommon and mucosal involvement is usually not seen.
Suspected cases of CREST syndrome can be confirmed by laboratory evaluation for the presence of anticentromere autoantibodies. Moreover, histologic examination reportedly can allow for differentiation between HHT and CREST syndrome 9 . In HHT, arterioles and venules communicate directly with each other in the absence of a capillary network. The dilated venules in HHT are reportedly surrounded by a thickened muscular layer 10 . In contrast, telangiectases in CREST syndrome show no muscular thickening. In addition, the presence of visceral involvement is most consistent with a diagnosis of HHT.
The dental practitioner should include HHT in the differential diagnosis when faced with a patient with multiple mucocutaneous telangiectases.
Additionally, the dental practitioner may be faced with a patient with HHT who presents with prolonged gingival hemorrhage 11 . Until the presence of pulmonary AVMs can be ruled out, antibiotic prophylaxis should be prescribed prior to providing surgical dental treatment to patients with suspected HHT. Russi et al 12 described a patient with multiple gingival telangiectases and periodontal abscesses who developed repeated episodes of septic pulmonary emboli. These emboli resolved only after correction of the patient's periodontal condition, suggesting a relationship to the presence of these gingival telangiectases.
From a dental perspective, only a limited number of articles dealing with HHT have been published in the English language dental literature in the past 10 years 11, 13,14 . Rhodus and Kuba 15 described a patient with HHT who also presented with florid osseous dysplasia. To date, no specific dental findings attributed to HHT have been reported.
We report the first published case of a patient with HHT who presented with advanced external cervical root resorption involving multiple teeth. In most cases, external cervical root resorption is not believed to be related to pulpal pathology 20 , but appears to be the result of injury to the cervical attachment apparatus. The exact mechanism of tooth resorption is poorly understood, but is believed to involve the action of osteoclast-like cells Osseous involvement, though quite rare in HHT, has been reported 27, 28, 29, 30 and ranges from classic vertebral hemangiomas to calvarial angiomatosis. We were unable to demonstrate any intrabony vascular process in our patient.
To date, there have been no published reports of root resorption associated with HHT. In our patient with HHT we were able to histologically demonstrate that gingival tissue removed from resorptive root defects contained 
